Research Associate/Senior Research Associate, Antibody Discovery

    Updated 30+ days ago
    Gaithersburg, MD 20877
    Full-time, Part-time
    Similar jobs pay $14.00 - $22.40
    Refer friends, get paid!

    Job Description

    Job Description

    If you find science, speed, and success exhilarating, you have come to the right place.

    Novavax, Inc. (Nasdaq: NVAX) is a late-stage biotechnology company that promotes improved health globally by discovering, developing, and commercializing innovative vaccines to prevent serious infectious diseases. Novavax is uniquely qualified to address the enduring need for innovative vaccines. We utilize our proprietary recombinant technology platform, which combines genetic engineering's power and speed to efficiently produce highly immunogenic nanoparticles designed to address urgent global health needs. We have more than a decade of experience contending with some of the world's most devastating diseases, including COVID-19, seasonal influenza, RSV, Ebola, MERS, and SARS. Hard-won lessons and significant advances illustrate that our proven technology has tremendous potential to make a substantial contribution to public health worldwide.

    We are seeking a highly motivated detailed oriented individual to serve as a Research Associate/ Senior Research Associate who will assist in evaluating immune responses in animal, generation and characterization of monoclonal antibodies. The selected candidate will be expected to participate in all aspects of this program which includes generation of hybridomas, antibody screening, developing and performing cell based assays and characterization of monoclonal antibodies. This will involve extensive hands on laboratory work, planning and data analysis. This position will be located at our Gaithersburg, MD facility and will report to a Scientist in the Antibody Discovery, Vaccine l Development department.

    Responsibilities include but are not limited to:

    • Evaluate immune response generated by vaccine candidate in mice.
    • Hybridoma Fusion, screening and clone selection including cloning and expansion.
    • Perform antibody characterization by molecular, immunological and virological assays such as ELISA, neutralization assay and Western blot analysis.
    • Ability to plan and work independently with minimal supervision
    • Assisting supervisor in data analysis.
    • General lab organization and maintenance including equipment maintenance and calibration; cost-effective management of material and reagent inventories.
    • Other responsibilities may be require during project studies.

    Minimum Requirements:

    • BS or MS in Biology/ Biochemistry or related field.
    • Minimum of 5 years' experience with BS degree, 2 years for Master's degree in research, or pharmaceutical and/or vaccine development field.
    • Experience in Hybridoma and mammalian cell culture required.
    • Knowledge and experience with monoclonal antibody technology desired.
    • Experience with cell based assays, ELISA and Western blotting techniques.
    • Excellent verbal, written communication and organizational skills.
    • Ability to work independently on project with minimal supervision.
    • Good Computer skills and experience with relevant software such as Softmax, Excel, PowerPoint, and PRISM.

    Novavax, Inc. (NASDAQ: NVAX), is a late-stage biotechnology company that drives improved health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. ResVax, its RSV vaccine for infants via maternal immunization, is the only vaccine in a Phase 3 clinical program and is designed to prevent severe lower respiratory tract infection, which is the second leading cause of death in children under one year of age worldwide. Novavax is also advancing NanoFlu, its quadrivalent influenza nanoparticle vaccine, to address key factors that can lead to the poor effectiveness of currently approved flu vaccines.

    Novavax is a leading innovator of recombinant vaccines; its proprietary recombinant technology platform combines the power and speed of genetic engineering to efficiently produce a new class of highly immunogenic nanoparticles addressing urgent global health needs.

    Our product pipeline targets a variety of infectious diseases, with clinical vaccine candidates for respiratory syncytial virus (RSV), Seasonal Influenza, Ebola virus (EBOV), and a preclinical program for a combination respiratory vaccine candidate, as well as other infectious disease vaccine candidates.

    Novavax is headquartered in Gaithersburg, Maryland with additional facilities in Uppsala, Sweden and Bohumil, Czech Republic. Novavax is traded on the Nasdaq Stock Market under the symbol NVAX and is dedicated to developing novel vaccines to address infectious disease.

    Novavax offers a base salary, annual bonus, equity grants, professional career development/growth opportunities, and a comprehensive benefits package including medical, dental, vision, Rx, STD, LTD, Life, Optional Life, 401(k) plan.

    Equal Opportunity Employer/Veterans/Disabled

    Novavax is an equal employment opportunity employer. Employment and advancement opportunities are available to all individuals on an at-will basis, regardless of their race, color, national origin, religion, ancestry, citizenship status, military or veteran status, sex, sexual orientation, gender identity or expression, age, marital status, family responsibilities, pregnancy, disability, genetic information, protective hairstyle, or any other characteristic protected by applicable federal, state, or local law.



    Job Posted by ApplicantPro

    Posting ID: 608517937Posted: 2021-03-21Job Title: Research